Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125095912 | 12509591 | 2 | F | 2016 | 20160912 | 20160629 | 20160920 | EXP | BR-DSJP-DSE-2016-121398 | DAIICHI | 0.00 | Y | 0.00000 | 20160920 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125095912 | 12509591 | 1 | PS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 20/12.5, UNK | Y | U | 21532 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 125095912 | 12509591 | 2 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 20/12.5, QD | Y | U | 41136 | 21532 | 1 | DF | FILM-COATED TABLET | QD | ||||
| 125095912 | 12509591 | 3 | SS | CARVEDILOL. | CARVEDILOL | 1 | 12.5, BID | 0 | 12.5 | MG | TABLET | BID | |||||||
| 125095912 | 12509591 | 4 | SS | RITMONORM | PROPAFENONE HYDROCHLORIDE | 1 | 300 MG, QD | 0 | 300 | MG | QD | ||||||||
| 125095912 | 12509591 | 5 | SS | ESPIRONOLACTONA | SPIRONOLACTONE | 1 | 25 MG, QD | 0 | 25 | MG | QD | ||||||||
| 125095912 | 12509591 | 6 | C | PURAN | LEVOTHYROXINE SODIUM | 1 | 25 NG, QD | 0 | 25 | NG | QD | ||||||||
| 125095912 | 12509591 | 7 | C | ROSUCOR | ROSUVASTATIN CALCIUM | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 125095912 | 12509591 | 8 | C | SPIRIVA RESPIMAT | TIOTROPIUM BROMIDE | 1 | 2.5, QD | 0 | 1 | DF | QD | ||||||||
| 125095912 | 12509591 | 9 | C | STRIVERDI RESPIMAT | OLODATEROL HYDROCHLORIDE | 1 | 2.5, QD | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125095912 | 12509591 | 1 | Hypertension |
| 125095912 | 12509591 | 3 | Product used for unknown indication |
| 125095912 | 12509591 | 4 | Product used for unknown indication |
| 125095912 | 12509591 | 5 | Product used for unknown indication |
| 125095912 | 12509591 | 6 | Hyperthyroidism |
| 125095912 | 12509591 | 7 | Blood cholesterol increased |
| 125095912 | 12509591 | 8 | Emphysema |
| 125095912 | 12509591 | 9 | Emphysema |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125095912 | 12509591 | HO |
| 125095912 | 12509591 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125095912 | 12509591 | Blood glucose increased | |
| 125095912 | 12509591 | Confusional state | |
| 125095912 | 12509591 | Fall | |
| 125095912 | 12509591 | Foot fracture | |
| 125095912 | 12509591 | Joint dislocation | |
| 125095912 | 12509591 | Malaise | |
| 125095912 | 12509591 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125095912 | 12509591 | 1 | 201606 | 201606 | 0 | |
| 125095912 | 12509591 | 2 | 20160620 | 0 | ||
| 125095912 | 12509591 | 3 | 201606 | 0 | ||
| 125095912 | 12509591 | 4 | 201606 | 0 | ||
| 125095912 | 12509591 | 5 | 201606 | 0 | ||
| 125095912 | 12509591 | 8 | 2015 | 0 | ||
| 125095912 | 12509591 | 9 | 2016 | 0 |